[1] 中华医学会传染病与寄生虫病学分会和肝病学分会.病毒性肝炎防治方案. 中华肝脏病杂志,2000,8（6）：324-329.
[2] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志,2011,14（2）：81-89.
[3] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝诊断标准. 中华肝脏病杂志,2003,11（2）：71.
[4] 王家祥,刘英慄. 脂肪肝的影像学诊断. 肝脏,2001.6:194-195.
[5] 倪燕君,刘厚钰,胡德昌,等. 脂肪肝临床病理分析. 中华消化杂志,2001,21（2）：98-101.
[6] Madan K,Batra Y,Jha JK,et al. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection. Trop Gastroenterol,2008,29（2）:59-61.
[7] Matthews GV,Avihingsanon A,Lewin SR,et al. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand. Hepatology,2008;48：1062-1069.
[8] Keeffe EB,Dieterich DT,Han SH,et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States:2008 Update. Clin Gastroenterol Hepatol,2008;6:1315-1341.
[9] Peter LM. Non-alcoholic steatohepatitis. Eur J Gastroenterol Hepatol,2004,16（11）:1079-1085.
[10] Bugianesi E,Leone N,Vanni E,et al. Expanding the natural history of nonalcoholic steatohepatitis:from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology,2002,123（1）:134-140.
[11] Ester V,Elisabetta B. The gut-liver axis in nonalcoholic fatty liver disease:Another pathway to insulin resistance. Hepatology, 2009,49（6）:1791-1793.
[12] Han DW. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol,2002,8（6）:961-965.
[13] 潘莉,韩真.脂肪细胞因子在非酒精性脂肪肝发病机制中的作用. 实用肝脏病杂志,2010,13（2）：151-153. |
